| 1 |
Kim HJ, Perlman D, Tomic R. Natural history of idiopathic pulmonary fibrosis [J]. Respir Med, 2015, 109(6): 661-670.
|
| 2 |
Wu H, Yu Y, Huang H, et al. Progressive pulmonary fibrosis is caused by elevated mechanical tension on alveolar stem cells [J]. Cell, 2020, 180(1): 107-121. e17.
|
| 3 |
Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibrosis [J]. Lancet Lond Engl, 2017, 389(10082): 1941-1952.
|
| 4 |
Cottin V, Wollin L, Fischer A, et al. Fibrosing interstitial lung diseases: knowns and unknowns [J]. Eur Respir Rev, 2019, 28(151): 180100.
|
| 5 |
Raghu G, Remy-Jardin M, Richeldi L, et al. Idiopathic pulmonary fibrosis(an update)and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline [J]. Am J Respir Crit Care Med, 2022, 205(9): e18-e47.
|
| 6 |
中华医学会呼吸病学分会, 中国医师协会呼吸医师分会.间质性肺疾病多学科讨论规范中国专家共识 [J]. 中华结核和呼吸杂志, 2023, 46(12): 1176-1188.
|
| 7 |
George PM, Spagnolo P, Kreuter M, et al. Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities [J]. Lancet Respir Med, 2020, 8(9): 925-934.
|
| 8 |
Temiz Karadag D, Cakir O, San S, et al. Association of quantitative computed tomography ındices with lung function and extent of pulmonary fibrosis in patients with systemic sclerosis [J]. Clin Rheumatol, 2022, 41(2): 513-521.
|
| 9 |
Miller MR, Crapo R, Hankinson J, et al. General considerations for lung function testing [J]. Eur Respir J, 2005, 26(1): 153-161.
|
| 10 |
Cj R, Tj C, Jl M, et al. A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung disease [J]. Eur Respir J, 2021, 58(6): 2100276.
|
| 11 |
Milad N, Esmaeil I, Atefeh A, et al. Lung ultrasound for assessing disease progression in UIP and NSIP: a comparative study with HRCT and PFT/DLCO [J]. BMC Pulm Med, 2025, 25(1): 11.
|
| 12 |
Volpicelli G. Lung sonography [J]. J Ultrasound Med, 2013, 32(1): 165-171.
|
| 13 |
Yang Y, Huang Y, Gao F, et al. Lung ultrasonography versus chest CT in COVID-19 pneumonia: a two-centered retrospective comparison study from China [J]. Intensive Care Med, 2020, 46(9): 1761-1763.
|
| 14 |
Yang Y, Lian J, Zhao Y, et al. Lung ultrasonography versus chest CT for assessing peripheric pulmonary lesions in hemorrhagic fever with renal syndrome: a prospective comparative study in China [J]. Eur Radiol, 2023, 33(7): 4895-4904.
|
| 15 |
Moazedi-Fuerst FC, Zechner PM, Tripolt NJ, et al. Pulmonary echography in systemic sclerosis [J]. Clin Rheumatol, 2012, 31(11): 1621-1625.
|
| 16 |
Moazedi-Fuerst FC, Kielhauser SM, Scheidl S, et al. Ultrasound screening for interstitial lung disease in rheumatoid arthritis [J]. Clin Exp Rheumatol, 2014, 32(2): 199-203.
|
| 17 |
Xie HQ, Zhang WW, Sun DS, et al. A simplified lung ultrasound for the diagnosis of interstitial lung disease in connective tissue disease: a meta-analysis [J]. Arthritis Res Ther, 2019, 21(1): 93.
|
| 18 |
Baldi G, Gargani L, Abramo A, et al. Lung water assessment by lung ultrasonography in intensive care: a pilot study [J]. Intensive Care Med, 2013, 39(1): 74-84.
|
| 19 |
Schneider F, Gruden J, Tazelaar HD, et al. Pleuropulmonary pathology in patients with rheumatic disease [J]. Arch Pathol Lab Med, 2012, 136(10): 1242-1252.
|
| 20 |
Sperandeo M, De Cata A, Molinaro F, et al. Ultrasound signs of pulmonary fibrosis in systemic sclerosis as timely indicators for chest computed tomography [J]. Scand J Rheumatol, 2015, 44(5): 389-398.
|
| 21 |
Pinal-Fernandez I, Pallisa-Nuñez E, Selva-O'Callaghan A, et al. Pleural irregularity, a new ultrasound sign for the study of interstitial lung disease in systemic sclerosis and antisynthetase syndrome [J]. Clin Exp Rheumatol, 2015, 33(4 Suppl 91): S136-S141.
|
| 22 |
Sperandeo M, Varriale A, Sperandeo G, et al. Transthoracic ultrasound in the evaluation of pulmonary fibrosis: our experience [J]. Ultrasound Med Biol, 2009, 35(5): 723-729.
|
| 23 |
Soldati G, Copetti R, Sher S. Sonographic interstitial syndrome: the sound of lung water [J]. J Ultrasound Med, 2009, 28(2): 163-174.
|
| 24 |
Buda N, Piskunowicz M, Porzezińska M, et al. Lung ultrasonography in the evaluation of interstitial lung disease in systemic connective tissue diseases: criteria and severity of pulmonary fibrosis-analysis of 52 patients [J]. Ultraschall Med Stuttg Ger, 1980, 2016, 37(4): 379-385.
|
| 25 |
吕秀章, 朱维维. 心肺联合超声临床应用: 回顾与展望 [J/CD]. 中华医学超声杂志(电子版), 2018, 15(7): 481.
|
| 26 |
Vasco PG, de Luna Cardenal G, Garrido IM, et al. Assessment of interstitial lung disease in Sjögren's syndrome by lung ultrasound: a pilot study of correlation with high-resolution chest tomography [J]. Intern Emerg Med, 2017, 12(3): 327-331.
|
| 27 |
Gasperini ML, Gigante A, Iacolare A, et al. The predictive role of lung ultrasound in progression of scleroderma interstitial lung disease [J]. Clin Rheumatol, 2020, 39(1): 119-123.
|
| 28 |
Manolescu D, Oancea C, Timar B, et al. Ultrasound mapping of lung changes in idiopathic pulmonary fibrosis [J]. Clin Respir J, 2020, 14(1): 54-63.
|
| 29 |
Gutierrez M, Bertolazzi C, Zozoaga-Velazquez E, et al.The value of ultrasound for detecting and following subclinical interstitial lung disease in systemic sclerosis [J]. Tomography, 2024, 10(4): 521-532.
|
| 30 |
Wang Y, Xie X, Zheng S, et al. Serum B-cell activating factor and lung ultrasound B-lines in connective tissue disease related interstitial lung disease [J]. Front Med, 2022, 9: 1066111.
|
| 31 |
Çakir Edis E, Hatipoğlu ON, Pamuk ÖN, et al. Effectiveness of thoracic ultrasonography in the evaluation of the severity of pulmonary involvement in patients with systemic sclerosis [J]. Arch Rheumatol, 2016, 31(4): 364-370.
|
| 32 |
Ziętkiewicz M, Buda N, Więsik-Szewczyk E, et al. Comparison of pulmonary lesions using lung ultrasound and high-resolution computed tomography in adult patients with primary humoral immunodeficiencies [J]. Front Immunol, 2022, 13: 1031258.
|
| 33 |
Tardella M, Di Carlo M, Carotti M, et al.Ultrasound B-lines in the evaluation of interstitial lung disease in patients with systemic sclerosis: Cut-off point definition for the presence of significant pulmonary fibrosis [J]. Medicine(Baltimore), 2018, 97(18): e0566.
|
| 34 |
Otaola M, Paulin F, Rosemffet M, et al. Lung ultrasound is a promising screening tool to rule out interstitial lung disease in patients with rheumatoid arthritis [J]. Respirol Carlton Vic, 2024, 29(7): 588-595.
|
| 35 |
Zhou B, Bartholmai BJ, Kalra S, et al. Lung US surface wave elastography in interstitial lung disease staging [J]. Radiology, 2019, 291(2): 479-484.
|
| 36 |
Zhang X, Zhou B, Kalra S, et al. An ultrasound surface wave technique for assessing skin and lung diseases [J]. Ultrasound Med Biol, 2018, 44(2): 321-331.
|
| 37 |
Milesi J, Boussuges A, Habert P, et al. Ultrasound evaluation of diaphragmatic function in patients with idiopathic pulmonary fibrosis: a retrospective observational study [J]. Respir Res, 2023, 24(1): 259.
|
| 38 |
Sonaglioni A, Caminati A, Nicolosi GL, et al. Influence of chest wall conformation on spirometry parameters and outcome in mild-to-moderate idiopathic pulmonary fibrosis [J]. Intern Emerg Med, 2022, 17(4): 989-999.
|
| 39 |
Sonaglioni A, Baravelli M, Vincenti A, et al. A new modified anthropometric haller index obtained without radiological exposure [J]. Int J Cardiovasc Imaging, 2018, 34(10): 1505-1509.
|
| 40 |
van Sloun RJG, Demi L. Localizing B-lines in lung ultrasonography by weakly supervised deep learning, in-vivo results [J]. IEEE J Biomed Health Inform, 2020, 24(4): 957-964.
|
| 41 |
Siebert JN, Hartley MA, Courvoisier DS, et al. Deep learning diagnostic and severity-stratification for interstitial lung diseases and chronic obstructive pulmonary disease in digital lung auscultations and ultrasonography: clinical protocol for an observational case-control study [J]. BMC Pulm Med, 2023, 23(1): 191.
|